Hospital Mortality

医院死亡率
  • 文章类型: Journal Article
    本研究包括最长的分析时间,西班牙文献中描述的髋部骨折发作次数最高(756,308)。我们发现,从2005年到2018年,年龄调整后的比率逐渐下降。我们认为这很重要,因为这可能意味着预防和治疗骨质疏松症等措施,或促进健康生活方式的计划,对髋部骨折发生率有积极影响。
    目的:描述2001年至2018年西班牙65岁或以上患者髋部骨折(HF)的病例和发生率的演变,并检查调整后发生率的趋势。
    方法:回顾性,观察性研究包括≥65岁急性HF患者。2001年至2018年的数据来自卫生部最低基本数据集的西班牙国家记录。我们分析了HF的病例,按性别划分的粗发病率和年龄调整率,住院时间(LOS)和住院死亡率,并使用连接点回归分析来探索时间趋势。
    结果:我们确定了756,308例HF病例。平均年龄增加2.5岁,LOS降低4.5天,住院死亡率为5.5-6.5%。HF病例增加了49%。每100,000原油率为533.3(95%置信区间[CI],532.1-534.5),增14.0%(95CI,13.7-14.2)。从2001年(535.7;95CI,529.9-541.5)到2005年(572.4;95CI,566.7-578.2),年龄调整后的HF发病率增加了6.9%,然后下降了13.3%,直到2017年(496.1,95CI,491.7-500.6)。Joinpoint回归分析表明,从2001年到2005年,年龄调整后的发病率每年逐渐增加1.9%,从2005年到2018年,每年逐渐减少-1.1%。在两种性别中都发现了类似的模式。
    结论:从2001年到2018年,西班牙≥65岁人群中HF的粗发病率逐渐增加。从2001年到2005年,年龄调整后的比率显着增加,从2005年到2018年逐渐下降。
    The present study includes the longest period of analysis with the highest number of hip fracture episodes (756,308) described in the literature for Spain. We found that the age-adjusted rates progressively decreased from 2005 to 2018. We believe that this is significant because it may mean that measures such as prevention and treatment of osteoporosis, or programs promoting healthy lifestyles, have had a positive impact on hip fracture rates.
    OBJECTIVE: To describe the evolution of cases and rates of hip fracture (HF) in patients 65 years or older in Spain from 2001 to 2018 and examine trends in adjusted rates.
    METHODS: Retrospective, observational study including patients ≥65 years with acute HF. Data from 2001 to 2018 were obtained from the Spanish National Record of the Minimum Basic Data Set of the Ministry of Health. We analysed cases of HF, crude incidence and age-adjusted rates by sex, length of hospital stay (LOS) and in-hospital mortality, and used joinpoint regression analysis to explore temporal trends.
    RESULTS: We identified 756,308 HF cases. Mean age increased 2.5 years, LOS decreased 4.5 days and in-hospital mortality was 5.5-6.5%. Cases of HF increased by 49%. Crude rate per 100,000 was 533.3 (95% confidence interval [CI], 532.1-534.5), increasing 14.0% (95%CI, 13.7-14.2). Age-adjusted HF incidence rate increased by 6.9% from 2001 (535.7; 95%CI, 529.9-541.5) to 2005 (572.4; 95%CI, 566.7-578.2), then decreased by 13.3% until 2017 (496.1, 95%CI, 491.7-500.6). Joinpoint regression analysis indicated a progressive increase in age-adjusted incidence rates of 1.9% per year from 2001 to 2005 and a progressive decrease of -1.1% per year from 2005 to 2018. A similar pattern was identified in both sexes.
    CONCLUSIONS: Crude incidence rates of HF in Spain in persons ≥65 years from 2001 to 2018 have gradually increased. Age-adjusted rates show a significant increase from 2001 to 2005 and a progressive decrease from 2005 to 2018.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    低收入和中等收入国家的医疗质量构成了重大挑战,导致可治疗条件导致死亡率上升。医疗机构认证是墨西哥前卫生改革的一部分,被提议作为一种提高医疗质量的机制。这项研究评估了墨西哥医院认证的表现,利用有效性指标,效率,和安全。采用纵向方法,采用受控中断时间序列分析(C-ITSA)和固定效应面板分析,来自墨西哥综合医院的行政数据受到审查。结果显示,墨西哥的医院认证未能提高医疗保健质量,令人不安的是,表明与医院死亡率增加相关的表现恶化。在医疗服务资金不足的情况下,事实证明,实施的认证模式在提高护理质量方面设计不足。对公立医院认证模式进行根本性的重新设计势在必行,强调结构强化和标准化流程的激励措施。解决提高医疗质量的关键挑战对墨西哥的医疗保健系统来说是当务之急,需要迅速采取行动,以实现有效获取,作为全民医疗保健覆盖的基准。
    Healthcare quality in low- and middle-income countries poses a significant challenge, contributing to heightened mortality rates from treatable conditions. The accreditation of health facilities was part of the former health reform in Mexico, proposed as a mechanism to enhance healthcare quality. This study assesses the performance of hospital accreditation in Mexico, utilizing indicators of effectiveness, efficiency, and safety. Employing a longitudinal approach with controlled interrupted time series analysis (C-ITSA) and fixed effects panel analysis, administrative data from general hospitals in Mexico is scrutinized. Results reveal that hospital accreditation in Mexico fails to enhance healthcare quality and, disconcertingly, indicates deteriorating performance associated with increased hospital mortality. Amidst underfunded health services, the implemented accreditation model proves inadequately designed to uplift care quality. A fundamental redesign of the public hospital accreditation model is imperative, emphasizing incentives for structural enhancement and standardized processes. Addressing the critical challenge of improving care quality is urgent for Mexico\'s healthcare system, necessitating swift action to achieve effective access as a benchmark for universal healthcare coverage.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    脓毒症是以高死亡率为特征的严重疾病。我们的目的是开发脓毒症不良结局的早期预后指标,利用容易获得的常规血液测试。对MIMIC-IV数据库中的脓毒症患者进行回顾性分析。我们进行了单变量和多变量回归分析,以确定与28天内住院死亡率相关的独立危险因素。使用Logistic回归将中性粒细胞与淋巴细胞比率(NLR)和中性粒细胞与血小板比率(NPR)合并为复合评分,表示为NLR_NPR。我们使用ROC曲线比较模型的预后表现和Kaplan-Meier存活曲线评估28天生存率。根据具体特征进行亚组分析以评估NLR_NPR在不同亚群中的适用性。本研究共纳入1263例脓毒症患者,其中179人在住院28天内死亡,1084人存活超过28天。多元回归分析确定的年龄,呼吸频率,中性粒细胞与淋巴细胞比率(NLR),中性粒细胞与血小板比率(NPR),高血压,序贯器官衰竭评估(SOFA)评分是影响脓毒症患者28天死亡率的独立危险因素(P<0.05)。此外,在基于血细胞相关参数的预测模型中,NLR_NPR综合评分对28天死亡率的预测价值最高(AUC=0.6666),其次是NLR(AUC=0.6456)和NPR(AUC=0.6284)。重要的是,NLR_NPR评分的表现优于常用的SOFA评分(AUC=0.5613)。亚组分析显示,NLR_NPR仍然是年龄亚组28天住院死亡率的独立危险因素,呼吸频率,SOFA,虽然不是在高血压亚组。来自常规血液测试的NLR和NPR的组合使用代表了脓毒症患者28天死亡率的容易获得且可靠的预测标志物。这些结果表明,临床医生应优先考虑NLR_NPR评分较高的患者,以进行更密切的监测以降低死亡率。
    Sepsis is a severe disease characterized by high mortality rates. Our aim was to develop an early prognostic indicator of adverse outcomes in sepsis, utilizing easily accessible routine blood tests. A retrospective analysis of sepsis patients from the MIMIC-IV database was conducted. We performed univariate and multivariate regression analyses to identify independent risk factors associated with in-hospital mortality within 28 days. Logistic regression was utilized to combine the neutrophil-to-lymphocyte ratio (NLR) and the neutrophil-to-platelet ratio (NPR) into a composite score, denoted as NLR_NPR. We used ROC curves to compare the prognostic performance of the models and Kaplan-Meier survival curves to assess the 28 day survival rate. Subgroup analysis was performed to evaluate the applicability of NLR_NPR in different subpopulations based on specific characteristics. This study included a total of 1263 sepsis patients, of whom 179 died within 28 days of hospitalization, while 1084 survived beyond 28 days. Multivariate regression analysis identified age, respiratory rate, neutrophil-to-lymphocyte ratio (NLR), neutrophil-to-platelet ratio (NPR), hypertension, and sequential organ failure assessment (SOFA) score as independent risk factors for 28 day mortality in septic patients (P < 0.05). Additionally, in the prediction model based on blood cell-related parameters, the combined NLR_NPR score exhibited the highest predictive value for 28 day mortality (AUC = 0.6666), followed by NLR (AUC = 0.6456) and NPR (AUC = 0.6284). Importantly, the performance of the NLR_NPR score was superior to that of the commonly used SOFA score (AUC = 0.5613). Subgroup analysis showed that NLR_NPR remained an independent risk factor for 28 day in-hospital mortality in the subgroups of age, respiratory rate, and SOFA, although not in the hypertension subgroup. The combined use of NLR and NPR from routine blood tests represents a readily available and reliable predictive marker for 28 day mortality in sepsis patients. These results imply that clinicians should prioritize patients with higher NLR_NPR scores for closer monitoring to reduce mortality rates.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:我们系统评估经皮冠状动脉介入治疗(PCI)后患者住院和30天死亡率风险的预测模型。
    方法:系统回顾和叙事综合。
    方法:搜索PubMed,WebofScience,Embase,科克伦图书馆,CINAHL,CNKI,万方数据库,VIP数据库和SinoMed的文献,截至2023年8月31日。
    方法:纳入的文献包括涉及年龄≥18岁PCI患者的中文或英文研究。这些研究旨在开发风险预测模型,包括队列研究等设计,病例对照研究,横断面研究或随机对照试验。每个预测模型必须至少包含两个预测因子。排除标准包括包括PCI术后死亡以外的其他结果的模型,缺乏研究设计的基本细节的文献,模型构建和统计分析,基于虚拟数据集的模型,以及会议摘要等出版物,灰色文学,非正式出版物,重复出版物,论文,审查或病例报告。我们还排除了侧重于模型的本地化适用性或比较有效性的研究。
    方法:两个独立的研究团队开发了基于CHecklist的标准化数据提取表格,用于关键评估和数据提取,用于系统回顾预测建模研究,以提取和交叉验证数据。他们使用预测模型偏差风险评估工具(PROBAST)来评估本综述中包含的模型开发或验证研究的偏差风险和适用性。
    结果:这篇综述包括28项研究和38个预测模型,曲线下面积值范围为0.81至0.987。一项研究有不清楚的偏见风险,虽然27项研究有很高的偏倚风险,主要是在统计分析方面。在25项研究中构建的模型缺乏临床适用性,其中21项研究包括术中或术后预测因素。
    结论:PCI术后患者的院内和30天死亡率预测模型的开发还处于早期阶段。强调临床适用性和预测稳定性至关重要。未来的研究应遵循PROBAST的低偏倚风险指南,优先考虑现有模型的外部验证,以确保可靠和广泛适用的临床预测。
    CRD42023477272。
    OBJECTIVE: We systematically assessed prediction models for the risk of in-hospital and 30-day mortality in post-percutaneous coronary intervention (PCI) patients.
    METHODS: Systematic review and narrative synthesis.
    METHODS: Searched PubMed, Web of Science, Embase, Cochrane Library, CINAHL, CNKI, Wanfang Database, VIP Database and SinoMed for literature up to 31 August 2023.
    METHODS: The included literature consists of studies in Chinese or English involving PCI patients aged ≥18 years. These studies aim to develop risk prediction models and include designs such as cohort studies, case-control studies, cross-sectional studies or randomised controlled trials. Each prediction model must contain at least two predictors. Exclusion criteria encompass models that include outcomes other than death post-PCI, literature lacking essential details on study design, model construction and statistical analysis, models based on virtual datasets, and publications such as conference abstracts, grey literature, informal publications, duplicate publications, dissertations, reviews or case reports. We also exclude studies focusing on the localisation applicability of the model or comparative effectiveness.
    METHODS: Two independent teams of researchers developed standardised data extraction forms based on CHecklist for critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies to extract and cross-verify data. They used Prediction model Risk Of Bias Assessment Tool (PROBAST) to assess the risk of bias and applicability of the model development or validation studies included in this review.
    RESULTS: This review included 28 studies with 38 prediction models, showing area under the curve values ranging from 0.81 to 0.987. One study had an unclear risk of bias, while 27 studies had a high risk of bias, primarily in the area of statistical analysis. The models constructed in 25 studies lacked clinical applicability, with 21 of these studies including intraoperative or postoperative predictors.
    CONCLUSIONS: The development of in-hospital and 30-day mortality prediction models for post-PCI patients is in its early stages. Emphasising clinical applicability and predictive stability is vital. Future research should follow PROBAST\'s low risk-of-bias guidelines, prioritising external validation for existing models to ensure reliable and widely applicable clinical predictions.
    UNASSIGNED: CRD42023477272.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    在西方,与广泛的肺炎严重程度指数(PSI)不同,国家早期预警评分2(NEWS2)通常仅使用床旁变量来预测疾病的严重程度。这项研究的目的是比较这些得分作为社区获得性肺炎(CAP)患者的死亡率预测因子。这项横断面研究是在Jinnah研究生医学中心进行的,卡拉奇,巴基斯坦,2020年对116例CAP患者进行了6个月的随访。吸入性肺炎病例,医院获得性肺炎,肺结核,肺栓塞,排除肺水肿。院内死亡率作为这项研究的结果。参与者的平均年龄为46.9±20.5岁。住院死亡率为45例(38.8%)。NEWS2在预测结果方面的敏感性为97.8%,但特异性仅为15.5%。而PSI较不敏感(68.9%)但更具体(50.7%),这表明与PSI相比,NEWS2是住院CAP患者中更敏感的死亡率预测评分。
    In the West, National Early Warning Score 2 (NEWS2) is commonly applied to predict the severity of illness using only bedside variables unlike the extensive Pneumonia Severity Index (PSI). The objective of this study was to compare these scores as mortality predictors in patients admitted with community acquired pneumonia (CAP). This cross-sectional study was conducted in Jinnah Postgraduate Medical Centre, Karachi, Pakistan, for six months in 2020 on 116 patients presenting with CAP. Cases of aspiration pneumonia, hospital acquired pneumonia, pulmonary tuberculosis, pulmonary embolism, and pulmonary oedema were excluded. In-hospital mortality was taken as the outcome of this study. The mean age of the participants was 46.9±20.5 years. The in-hospital mortalities were 45(38.8%). NEWS2 was 97.8% sensitive but only 15.5% specific in predicting the outcome, whereas PSI was less sensitive (68.9%) but more specific (50.7%), which showed that in comparison with PSI, NEWS2 is a more sensitive mortality predicting score among hospitalised CAP patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    COVID-19大流行构成了全球挑战,导致外科服务发生根本性变化。该研究的主要目的是评估COVID-19对巴西大都市地区择期手术和紧急手术的影响。次要目标是比较大流行之前和期间的术后住院死亡率。
    时间序列队列研究,包括在联邦区公共卫生系统医院接受择期或急诊手术的所有患者的数据,巴西,2018年3月至2022年2月,使用2022年9月30日从巴西卫生部医院信息系统(SIH/DATASUS)提取的数据。使用因果影响分析来评估COVID-19对择期和急诊手术以及医院死亡率的影响。
    在研究期间有174,473例手术。总体下降(每周绝对效果:-227.5;95%CI:-307.0至-149.0),选修(每周绝对效果:-170.9;95%CI:-232.8至-112.0),COVID-19期间的急诊手术(每周绝对效果:-57.7;95%CI:-87.5至-27.7)。比较COVID-19发病前后的手术,急诊手术增加了(53.0%对68.8%,P<0.001),住院时间无统计学意义(P=0.112)。COVID-19大流行对术后住院死亡率的影响无统计学意义(每周绝对效应:2.1,95%CI:-0.01至4.2)。
    我们的研究表明,在COVID-19大流行期间,选择性手术和紧急手术减少,可能是由于手术服务中断。这些发现强调,实施有效的策略以防止危机时期手术等待名单的积累并改善手术患者的预后至关重要。
    UNASSIGNED: The COVID-19 pandemic posed a worldwide challenge, leading to radical changes in surgical services. The primary objective of the study was to assess the impact of COVID-19 on elective and emergency surgeries in a Brazilian metropolitan area. The secondary objective was to compare the postoperative hospital mortality before and during the pandemic.
    UNASSIGNED: Time-series cohort study including data of all patients admitted for elective or emergency surgery at the hospitals in the Public Health System of Federal District, Brazil, between March 2018 and February 2022, using data extracted from the Hospital Information System of Brazilian Ministry of Health (SIH/DATASUS) on September 30, 2022. A causal impact analysis was used to evaluate the impact of COVID-19 on elective and emergency surgeries and hospital mortality.
    UNASSIGNED: There were 174,473 surgeries during the study period. There was a reduction in overall (absolute effect per week: -227.5; 95% CI: -307.0 to -149.0), elective (absolute effect per week: -170.9; 95% CI: -232.8 to -112.0), and emergency (absolute effect per week: -57.7; 95% CI: -87.5 to -27.7) surgeries during the COVID-19 period. Comparing the surgeries performed before and after the COVID-19 onset, there was an increase in emergency surgeries (53.0% vs 68.8%, P < 0.001) and no significant hospital length of stay (P = 0.112). The effect of the COVID-19 pandemic on postoperative hospital mortality was not statistically significant (absolute effect per week: 2.1, 95% CI: -0.01 to 4.2).
    UNASSIGNED: Our study showed a reduction in elective and emergency surgeries during the COVID-19 pandemic, possibly due to disruptions in surgical services. These findings highlight that it is crucial to implement effective strategies to prevent the accumulation of surgical waiting lists in times of crisis and improve outcomes for surgical patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:使用评分系统有助于更快地识别败血症患者,尤其是那些有致命危险的人.最佳评分系统不存在,所以寻找最优的总是当前的。这项研究的目的是评估六个评分系统在预测急诊科败血症患者24小时死亡率方面的预后价值。
    方法:在贝尔格莱德塞尔维亚大学临床中心(UCCS)急诊中心(EC)的急诊分诊室(ETR)进行了一项观察性回顾性研究。连续败血症患者,根据脓毒症-3的定义,不管有没有休克,本研究将患者提交给ETR,然后在重症监护病房住院。从医院信息系统或国家死亡率数据库中提取24小时内和第28天的死亡率数据。评分系统包括序贯器官衰竭评估(SOFA),快速序贯器官衰竭评估(qSOFA),全身炎症反应综合征(SIRS),国家预警评分(NEWS),急诊脓毒症患者评估(SPEED),并利用现有数据对所有患者的急诊脓毒症(MEDS)死亡率进行分析.这项研究的主要结果是在分诊后24小时内死亡。使用接收器操作特征(ROC)分析来确定最有效的评分系统。然后将乳酸盐添加到该系统中以提高其预测准确性。
    结果:纳入研究的120例患者中有19例(15.8%)在分诊后24小时内死亡。28天死亡率为55%。SOFA评分对24小时死亡率的预测价值最高,但总体上只有中等程度的预测。受试者工作曲线下面积(AUC)为0.755(95%CI0.625-0.885)。速度,MEDS,和NEVS表现出适度的辨别能力[0.673(95%CI0.543-0.803),0.665(95%CI0.536-0.794),0.630(95%CI0.528-0.724)],而SIRS和qSOFA在预测24小时死亡率方面仍然微不足道。添加乳酸可提高SOFA评分的预测值(AUC0.865,95%CI0.736-0.995;p=0.0081)。所有评分对28天死亡率表现出更好和令人满意的预测能力。
    结论:SOFA,加入乳酸,是一种复杂但可靠的工具,用于对急诊科就诊的败血症患者进行早期分层。
    OBJECTIVE: The use of scoring systems contributes to the faster identification of septic patients, especially those at a high risk of a fatal outcome. The best scoring system does not exist, so the search for the optimal one is always current. The aim of this study is to estimate the prognostic value of the six scoring systems in predicting 24-hour mortality among septic patients presented at the emergency department.
    METHODS: An observational retrospective study was conducted in the Emergency Triage Room (ETR) of the Emergency Center (EC) at the University Clinical Center of Serbia (UCCS) in Belgrade. Consecutive septic patients, according to the Sepsis-3 definition, with or without shock, presented to the ETR and then hospitalized in Intensive Care Units were included in the study. Mortality data within 24 h and on the 28th day were extracted from the Hospital information system or the National mortality database. Scoring systems including sequential organ failure assessment (SOFA), quick sequential organ failure assessment (qSOFA), systemic inflammatory response syndrome (SIRS), National early warning score (NEWS), sepsis patient evaluation in the emergency department (SPEED), and mortality in emergency department sepsis (MEDS) were analyzed for all patients utilizing the available data. The primary outcome of this study was death within 24 hours of triage. Receiver operating characteristic (ROC) analysis was used to determine the most effective scoring system. Lactate was then added to this system to enhance its predictive accuracy.
    RESULTS: Nineteen out of 120 patients included in the study (15.8%) experienced death within 24 hours of triage. The twenty-eight-day mortality rate was 55%. SOFA score demonstrated the highest predictive value for 24-hour mortality but was only moderately predictive overall, with an area under the receiver operating curve (AUC) of 0.755 (95% CI 0.625-0.885). SPEED, MEDS, and NEVS exhibited modest discriminatory power [0.673 (95% CI 0.543-0.803), 0.665 (95% CI 0.536-0.794), 0.630 (95% CI 0.528-0.724)], while SIRS and qSOFA remained insignificant in predicting 24-hour mortality. The predictive value of the SOFA score was increased by the addition of lactate (AUC 0.865, 95% CI 0.736-0.995; p=0.0081). All scores demonstrated better and satisfactory predictive power for 28-day mortality.
    CONCLUSIONS: SOFA, with the addition of lactate, is a complex but reliable tool for the early stratification of septic patients who are presenting at an emergency department.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:在急性呼吸窘迫综合征(ARDS)患者中使用无创通气仍存在争议。由于高患者量和全球资源紧张,COVID-19大流行带来了挑战。
    目的:确定在因SARS-CoV-2肺炎引起的中度至重度ARDS的成年患者中使用无创通气之间的关系,进展到插管,医院死亡率。
    方法:这项回顾性队列研究纳入了机构COVID-19注册的患者。如果成年患者在2020年3月1日至2022年3月31日期间因COVID-19入院,并发展为中度至重度ARDS,则将其包括在内。主要结果是接受无创通气或机械通气患者的插管进展和住院死亡率。次要结果是无插管无创通气治疗成功。
    结果:在823名符合纳入标准的患者中,454例(55.2%)未接受无创通气,369例(44.8%)接受无创通气。接受无创通气的患者比未接受无创通气的患者更可能需要机械通气。在需要气管插管的患者中,接受无创通气的患者死亡的可能性较高.与未接受无创通气的患者相比,接受无创通气的患者在没有插管的情况下出院的严重程度调整后的生存几率较低。
    结论:接受无创通气治疗的SARS-CoV-2肺炎导致的中度至重度ARDS患者进展为气管插管和住院死亡率的可能性增加。
    BACKGROUND: Use of noninvasive ventilation in patients with acute respiratory distress syndrome (ARDS) is debated. The COVID-19 pandemic posed challenges due to high patient volumes and worldwide resource strain.
    OBJECTIVE: To determine associations between use of noninvasive ventilation in adult patients with moderate to severe ARDS due to SARS-CoV-2 pneumonia, progression to intubation, and hospital mortality.
    METHODS: This retrospective cohort study included patients in an institutional COVID-19 registry. Adult patients were included if they were admitted for COVID-19 between March 1, 2020, and March 31, 2022, and developed moderate to severe ARDS. Primary outcomes were progression to intubation and hospital mortality in patients who received noninvasive ventilation or mechanical ventilation. A secondary outcome was successful treatment with noninvasive ventilation without intubation.
    RESULTS: Of 823 patients who met inclusion criteria, 454 (55.2%) did not receive noninvasive ventilation and 369 (44.8%) received noninvasive ventilation. Patients receiving noninvasive ventilation were more likely to require mechanical ventilation than were patients not receiving noninvasive ventilation. Among patients requiring endotracheal intubation, those receiving noninvasive ventilation had a higher likelihood of mortality. Patients receiving noninvasive ventilation had lower severity-adjusted odds of survival to discharge without intubation than did patients not receiving noninvasive ventilation.
    CONCLUSIONS: Patients with moderate to severe ARDS due to SARS-CoV-2 pneumonia treated with noninvasive ventilation had increased likelihood of progression to endotracheal intubation and hospital mortality.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:本研究旨在评估最初进入麻醉科和重症监护病房的院外心脏骤停(OHCA)的急性心肌梗死(AMI)患者的死亡率和预后,并与最初进入心脏中心(CC)的患者进行比较。
    背景:全球急性冠状动脉综合征(ACS)登记通常会忽略最初进入麻醉科和重症监护病房的OHCA患者。这种排除可能导致全球急性MI后患者死亡率被低估。
    方法:对2014年在单中心(麻醉科和重症监护室)住院的患者进行了回顾性分析,普雷索夫的J.A.Reiman教学医院,斯洛伐克。在医院评估生存率,在30天,在五年内每年。分别对STEMI和NSTEMI患者进行分析,特别是在医院早期阶段。
    结果:在OHCA组中,52%的STEMI患者经历了院内死亡,而CC组仅报告3%的死亡率。STEMI患者的总住院死亡率为6.69%。在OHCA组的NSTEMI患者中,住院死亡率达到50%,CC组为4.33%。所有NSTEMI患者的中心总死亡率为6.09%。
    结论:尽管OHCAMI患者的短期预后不良,30天死亡率为54.9%,对于那些在心脏骤停后存活了最初30天并成功出院的人,长期预后与无OHCA的MI患者一致。根据这些发现,将所有MI患者(来自OHCA组和CC组)纳入全球ACS登记可显著提高院内死亡率和30日死亡率(表.3,图。4,参考。21).
    OBJECTIVE: This study aimed to assess the mortality and prognosis of acute myocardial infarction (AMI) patients with out-of-hospital cardiac arrest (OHCA) initially admitted to Department of Anesthesiology and Intensive Care in comparison with patients initially admitted to Cardiac Centre (CC).
    BACKGROUND: Global acute coronary syndrome (ACS) registries often omit patients with OHCA initially admitted to anaesthesiology and intensive care units. This exclusion may lead to underestimated mortality rates in patients following acute MI worldwide.
    METHODS: A retrospective analysis was conducted in patients admitted in 2014 to the (Department of Anesthesiology and Intensive Care) at a single center, J.A. Reiman Teaching Hospital in Presov, Slovakia. Survival rates were evaluated in-hospital, at 30 days, and annually over a five-year period. Patients with STEMI and NSTEMI were analyzed separately, particularly during the early in-hospital phase.
    RESULTS: In the OHCA group, 52% of STEMI patients experienced in-hospital mortality, whereas the CC group reported only 3% mortality. The total hospital mortality for STEMI patients was 6.69%. Among NSTEMI patients in the OHCA group, in-hospital mortality reached 50%, compared to 4.33% in the CC group. The total center mortality for all NSTEMI patients was 6.09%.
    CONCLUSIONS: Although the short-term prognosis for MI patients with OHCA is unfavorable, with a 30-day mortality rate of 54.9%, for those who survive the initial 30 days following cardiac arrest and are successfully discharged from the hospital, the long-term prognosis aligns with MI patients without OHCA. In light of these findings, the inclusion of all patients with MI (from both OHCA and CC groups) in global ACS registries could significantly raise in-hospital and 30-day mortality rates (Tab. 3, Fig. 4, Ref. 21).
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:中性粒细胞与淋巴细胞比率(NLR)被认为是死亡率和其他主要心脏事件的预后生物标志物。这项研究调查了NLR在预测接受经皮冠状动脉介入治疗(PCI)的ST段抬高型心肌梗死(STEMI)患者的院内和长期预后方面的功效。
    方法:电子数据库(PUBMED,科克伦中部,ERIC,Embase,奥维德,和GoogleScholar)一直搜索到2022年6月,以确定接受PCI的STEMI患者的研究。风险比和平均差异(MD),以及它们相应的95%置信区间(Cis)和标准偏差(SD),使用随机效应模型进行汇总。该荟萃分析已在Prospero上注册(ID:CRD42022344072)。
    结果:共纳入35项研究,共28,756名患者。汇总估计显示主要结局的发生率增加;院内全因死亡率(RR=3.52;95%CI=2.93-4.24),长期全因死亡率(HR=1.07;95%CI=1.00-1.14),(RR=3.32;95%CI=2.57-4.30);院内心血管死亡率(RR=2.66;95%CI=2.04-3.48),长期心血管死亡率(RR=6.67;95%CI=4.06-10.95);院内主要不良心血管事件(MACE)(RR=1.31;95%CI=1.17-1.46),长期MACE(RR=2.92;95%CI=2.16-3.94);NLR高患者与NLR低患者相比的住院时间(WMD=0.60天;95%CI=0.40-0.79).
    结论:NLR可能是对接受PCI的STEMI患者进行预后(院内)和分层的有价值的工具。
    BACKGROUND: Neutrophil to lymphocyte ratio (NLR) has been considered a prognostic biomarker of mortality and other major cardiac events. This study investigates NLR\'s efficacy in predicting in-hospital and long-term outcomes in patients with ST-segment elevated myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI).
    METHODS: Electronic databases (PUBMED, Cochrane CENTRAL, ERIC, Embase, Ovid, and Google Scholar) were searched till June 2022 to identify studies having STEMI patients who underwent PCI. Risk ratios and mean differences (MDs), along with their corresponding 95% confidence intervals (Cis) and standard deviations (SDs), were pooled using a random-effect model. This meta-analysis has been registered on Prospero (ID: CRD42022344072).
    RESULTS: A total of 35 studies with 28,756 patients were included. Pooled estimates revealed an increased incidence of primary outcomes; in-hospital all-cause mortality (RR = 3.52; 95% CI = 2.93-4.24), long-term all-cause mortality (HR = 1.07; 95% CI = 1.00-1.14), (RR = 3.32; 95% CI = 2.57-4.30); in-hospital cardiovascular mortality (RR = 2.66; 95% CI = 2.04-3.48), long-term cardiovascular mortality (RR = 6.67; 95% CI = 4.06-10.95); in-hospital major adverse cardiovascular events (MACE) (RR = 1.31; 95% CI = 1.17-1.46), long-term MACE (RR = 2.92; 95% CI = 2.16-3.94); length of hospital stay (WMD = 0.60 days; 95% CI = 0.40-0.79) in patients with high NLR compared to those with a low NLR.
    CONCLUSIONS: NLR might be a valuable tool for prognostication (in-hospital) and stratification of patients with STEMI who underwent PCI.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号